期刊文献+

糖尿病肾病微量白蛋白尿期患者危险因素的回顾性分析

Retrospective analysis of risk factors in patients with diabetic nephropathy during the microalbumin phase
下载PDF
导出
摘要 目的分析糖尿病肾病微量白蛋白尿期的危险因素。方法回顾性分析2015年至2016年西南医科大学附属中医医院内分泌科糖尿病患者314例,收集患者相关临床资料:年龄、糖尿病病程,眼底病变,血压,ACR(尿微量白蛋白/肌酐比值)等资料。分析糖尿病肾病微量白蛋白尿期的相关影响因素。结果两组患者糖尿病病程、收缩压(SBP)、舒张压(DBP)、LDL-C和HDL-C间差异有统计学意义(P<0.05),FPG、年龄及TG间差异无统计学意义(P>0.05)。Logistic回归分析显示,SBP、LDL-C是糖尿病肾病微量白蛋白尿期的独立危险因素(P<0.05),HDL-C是糖尿病肾病微量白蛋白尿期的保护因素(P<0.05)。结论 SBP、LDL-C是糖尿病肾病微量白蛋白尿期的危险因素。HDL-C是糖尿病肾病微量白蛋白尿的保护性因素。 Objective To analyze the risk factors of microalbumin in the urinary phase of diabetic nephropathy. Methods The clinical data of 314 patients with endocrine department diabetes in the affiliated traditional Chinese medicine hospital of Southwest Medical University from 2015 to 2016 were retrospectively analyzed. The clinical data were collected: age,diabetes course,ocular fundus lesions,blood pressure,ACR( urine microalbumin/creatinine ratio) and so on. The related factors of microalbumin in the urinary phase of diabetic nephropathy were analyzed. Results There were significant differences in diabetes course,systolic pressure( SBP),diastolic pressure( DBP),LDL-C and HDL-C between the two groups( P05). Logitic regression analysis shows that SBP and LDL-C are independent risk factors for the microalbumin urine phase of diabetic nephropathy. Conclusion SBP and LDL-C are risk factors for microalbumin in diabetic nephropathy. HDL-C is a protective factor for microalbuminuria in diabetic nephropathy.
作者 段莉 张琼
出处 《现代医学与健康研究电子杂志》 2018年第10期3-4,共2页 Modern Medicine and Health Research
关键词 糖尿病肾病 微量白蛋白尿期 危险因素 diabetic nephropathy microalbumin urine phase risk factors
  • 相关文献

参考文献4

二级参考文献34

  • 1侯凡凡,马志刚,梅长林,戎殳,黄颂敏,刘先蓉,袁伟杰,郭云珊,王莉,何强,王秀玲,桑晓红,栗霄立.中国五省市自治区慢性肾脏病患者心血管疾病的患病率调查[J].中华医学杂志,2005,85(7):458-463. 被引量:183
  • 2施惠碧,黄开群.糖尿病肾病蛋白质饮食控制率低的调查分析及对策[J].实用医技杂志,2007,14(3):338-340. 被引量:1
  • 3Rocco MV, Berns JS. KDOQI Clinical Practice Guideline for Diabetes and CKD : 2012 Update [ J ]. American Journal of Kidney Diseases, 2012, 60 (5): 850-886.
  • 4Jardine MJ, Hata J, Woodward M, et al. Prediction of kidney - relat- ed outeomes in patients with type 2 diabetes [J]. American Journal ot Kidney Diseases, 2012, 60 (5): 770-778.
  • 5Gross JL, De Azevedo MJ, Silveiro SP, et al. Diabetic nephropathy: diagnosis, prevention, and treatment [J] Diabetes Care, 2005, 28 (1): 164 -176.
  • 6American Diabetes Association. Standards of medical care in diabetes - 2009 [J]. Diabetes Care, 2009, 32 (Suppl 1): S13-S61.
  • 7Hilden J, Glasziou P. Regret graphs, diagnostic uncertainty and Youden's Index[J]. Statistics in Medicine, 1996, 15 (10):969- 986.
  • 8Singh SR, Ahmad F, Lal A, et al. Efficacy and safety of insulin ana- logues for the management of diabetes mellitus: a meta - analysis [ J] Canadian Medical Association Journal, 2009, 180 (4) : 385 -397.
  • 9Bed T, Hunsicker LG, Lewis JB, et al. Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropa- thy Trial [ J ]. Journal of the American Society of Nephrology, 2005, 16 (7): 2170-2179.
  • 10Shichiri M, Kishikawa H, Ohkubo Y, et al. Long - term results of the Kumamoto Study on optimal, diabetes control in type 2 diabetic patients [Jl. Diabetes Care, 2000, 23 (Suppl 2) : B21 -B29.

共引文献203

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部